chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a male who on 06-NOV-2007 was vaccinated with a 0.65 mL dose of ZOSTAVAX. On 09-NOV-2007 the patient developed shingles. Unspecified medical attention was sought. The outcome was reported as not recovered. There was no product quality complaint. Additional information is expected. Follow-up information has been received which indicated that the patient is a 70-year-old male who on 07-Nov-2007 (previously reported as 06-Nov-2007) was vaccinated subcutaneously in the upper arm. On 13-Nov-2007, one week after vaccination, (previously reported as 09-Nov-2007) the patient developed shingles. The outcome is reported as unknown. Additional information is expected.
When I woke up my right hand was probably 3 times the size of left hand, and stomach pain, and nausea. I wasn't able to do my normal daily activities (open water bottle). It took about 48 hours to use my right hand again. This was similar to Hep B reaction. I went to ER on November 18, 2021 I was feeling dizzy had a CT scan with IV dye showed enlarged uterus. Since the vaccine my menstrual has been off.
Information was received from a pharmacist via a company representative referring to a 54 years old female patient. There was no information about the patients medical history and concurrent condition. On 05-AUG-2015 the patient was vaccinated with ZOSTAVAX vial subcutaneously (strength, dose, and lot number unknown). Concomitant therapy was unknown. On 08-AUG-2015 the patient returned to the pharmacy and the patient had a hard knot the size of a quarter under her skin where the shot was received (the onset date of the adverse event was on an unspecified date in AUGUST 2015). The patient did not seek medical attention and no treatment was given to her. The outcome of the event was unknown. Additional information has been requested.
Extreme itchy palms of hands and bottom of feet for 2 weeks. Prednisone was given and it finally went away. Onset of severe seasonal allergies and new onset of asthma. Was prescribed an inhaler which has helped my nightly coughing fits but I am still experiencing asthma symptoms which I never had before the vaccine.   New lump in right breast. Mammogram scheduled for 6/23/21
Rash HIVES, EAR FULLNESSA Narrative:  Patient developed skin rash/hives immediately after the vaccine injection. She was treated with Benadryl 50mg PO . The reaction improved spontaneously
hosp employee recv vax 12AUG96 & 21AUG96 pt devel fever, malaise, cough;23AUG96 rash & severe joint pain;disease process (rash, fever, pain) lasted 7 days;measles;
Saw patient 4 days following immunization. Local induration, erythema 4" around vaccine site. C/O arm discomfort. Treated as cellulitis with Duricef since Benadryl for allergic reaction was not effective in decreasing symptoms.
Weakness low grade fever turning into a high grade fever can't get out of bed, don't talk very much arms numb for 7 days very quiet no interaction two and a half months
Went hiking in the morning of the 25th.. Got home at 1pm.  At around  1;30pm started experiencing nausea  and vomited 4 times. Went to bed, felt tired and nauseated but did not vomit again. By 8pm I felt much better and have had no symptoms since.
My period came and it was very very heavy for about 15 days or more. I was bleeding through pads every hour with clots of Blood. After about 2 weeks I went to my Dr and I had an abdominal ultrasound. Doctor stated that I was just actively bleeding and to remove the nuvaring and prescribed tranexamic acid. I never took the medication and after 3 or 4 days bleeding stopped on its own.
chills; increased heart rate; poor sleep; fatigued; This is a spontaneous report from a contactable consumer.  A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3247), via an unspecified route of administration in the right arm on 25Jan2021, at 12:15 as single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported.  On 26Jan2021, at 12:15 the patient experienced chills, increased heart rate, poor sleep, and fatigued, which were non-serious.  The patient underwent lab tests and procedures which included heart rate: increased on  26Jan2021. Details were as follows: hours after injection (just after midnight), the patient had chills, increased heart rate and poor sleep; next day  she was fatigued and side effects subsided 24 hours after onset (midnight). The outcome of chills, increased heart rate, poor sleep, and fatigued was recovered in Jan2021, with no treatment  No follow-up attempts are possible. No further information is expected.
Pain and golf ball sized knot immediately developed in arm which did not recede for 90+ days. Dizziness & flu like symptoms began within 48 hours. Was seen by civilian doctor on numerous visits due to flu like symptoms with negative tests between 2009 and 2019. Numbness and tingling in legs began in 2009. Chronic widespread pain began in 2013, joint pain level 5+ more than 50% of the time.
Pt received 1st dose of Pfizer, was seated and fainted about 30 seconds later. Pt came to after about 20 seconds and stated he was ok just light headed, skin was clammy, pulse was normal, pt stated no issues breathing and none were apparent. EMTs arrived shortly after pt was taken to hospital in the care of EMTs
Circum-oral numbness; This is a spontaneous report from a contactable consumer reporting for himself (patient). This 59-year-old male patient received the first dose of BNT162B2 via an unspecified route of administration in the left arm on 15Dec2020 at 18:00 at single dose for immunisation. Relevant medical history included penicillin allergy. Concomitant medications were not reported. On 15Dec2020 at 18:30, the patient experienced circum-oral numbness. The patient did not receive corrective treatments for the reported event. The facility where the vaccine was administered was hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination he had not been tested for COVID-19. The outcome of the event was unknown.  The information on the lot/batch number has been requested.
Patient stated that after receiving the 1st dose of the vaccine she felt a slight fever,  then when she was breast feeding the same day the baby started presenting with flu like symptoms the same day
POSITIVE FOR COVID-19; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: diabetic, high blood pressure, and high cholesterol. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On AUG-2021, the patient experienced positive for covid-19. Laboratory data included: SARS-CoV-2 test (NR: not provided) false negative, positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from positive for covid-19. This report was non-serious.
This spontaneous report was received from a nurse refers to two patients of unknown age and gender. Medical history was not reported. The nurse informed that on 27-JUN-2014 the patients were vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J008728, expiration date: 26-JUL-2015. That may had been improperly stored since February 2014. The thermometer battery ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temperature the M-M-R II could had been exposed was 70F. Also stated that was no way to determine what the exact temperature was at any given time after 01-FEB-2014 since the battery in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Narrative: The patient is a 75-year-old with a history of prostate cancer and more recent diagnosis of adenocarcinoma of the pancreas who was most recently discharged from inpatient on 5/14/2021 with weight loss and hypokalemia. Pt died at home in home hospice care on 6/6/2021. Pt had received covid vaccines on 1/29/21 and on 3/1/2021. It appears death is not related to vaccinations.
Case number PHEH2014US014079, is an initial spontaneous report from a health care professional received on 07 Jul 2014. This report refers to a 10-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: A12132) intramuscularly at a dose of 0.5 ml on 02 Jul 2014, that had a temperature excursion to 9 degrees Celsius for 1.5 hours on 01 Jul 2014. No adverse event was reported following the medication error (incorrect storage of drug).
Information has been received from a pharmacist referring to a 60 year old female patient. There were no pertinent medical history and drug reactions or allergies. On 14-SEP-2015, the patient was vaccinated with ZOSTAVAX (lot number, expiration date, dose and route were unknown). There were not concomitant medications. On 15-SEP-2015, the patient reported to the pharmacist that she developed an unspecified fever and headache, ibuprofen (unspecified dose and frequency) was given for the events. No lab diagnostics studies were performed. The outcome of th events were unknown. The causality between the events and ZOSTAVAX were unspecified. Additional information has been requested.
classic signs of "covid arm"  red , itchy and sore- just reported today 4/13/2021
Immunocompromised patient received booster dose instead of third dose.; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Immunocompromised patient received booster dose instead of third dose.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Immunocompromised patient received booster dose instead of third dose.). At the time of the report, INCORRECT DOSE ADMINISTERED (Immunocompromised patient received booster dose instead of third dose.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were reported.  A patient got the first two shots of the Moderna vaccine. Later, patient received the Moderna booster shot. Two weeks AFTER the booster, the patient found out they are immunocompromised.  Company comment:  This case concerns a patient of an unknown age and gender who was Immunocompromised received the booster dose instead of the full dose of the vaccine. Reportedly, two weeks after vaccination with the booster dose, the patient found out that the patient was immunocompromised. The patient received the booster dose instead of full dose of the vaccine, which is considered to be Incorrect dose administered. No adverse events were reported. The company causality for this event is not applicable. Sender's Comments: This case concerns a patient of an unknown age and gender who was Immunocompromised received the booster dose instead of the full dose of the vaccine. Reportedly, two weeks after vaccination with the booster dose, the patient found out that the patient was immunocompromised. The patient received the booster dose instead of full dose of the vaccine, which is considered to be Incorrect dose administered. No adverse events were reported. The company causality for this event is not applicable.
Right arm is bigger than left arm.; After 1st vaccine my right arm was little bigger than left arm but after 2nd vaccine it got worst; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (Right arm is bigger than left arm.) and CONDITION AGGRAVATED (After 1st vaccine my right arm was little bigger than left arm but after 2nd vaccine it got worst) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 024M20A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included FLUDROCORTISONE for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Right arm is bigger than left arm.) (seriousness criterion hospitalization) and CONDITION AGGRAVATED (After 1st vaccine my right arm was little bigger than left arm but after 2nd vaccine it got worst) (seriousness criterion hospitalization). The patient was hospitalized on 17-Apr-2021 due to CONDITION AGGRAVATED and PERIPHERAL SWELLING. At the time of the report, PERIPHERAL SWELLING (Right arm is bigger than left arm.) and CONDITION AGGRAVATED (After 1st vaccine my right arm was little bigger than left arm but after 2nd vaccine it got worst) outcome was unknown.            The patient also reported taking an unspecified birth control pill concomitantly. The patient reported going to the ER on 17-Apr-2021 due to possible blood clot in right arm. The doctor did not find any blood clot, and the patient was not prescribed anything.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the event is not applicable.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   This case was linked to US-MODERNATX, INC.-MOD-2021-148205 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: No new information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-148205:First Dose Case
Bruising and pain at injection site beginning shortly after administration.  Pain continued from 10/7/22 until present with limited range of motion in left shoulder without pain.  Pain has diminished some since injection, but is still causing discomfort in daily activities.
shock sensation that would travel from her shoulder to her belly, to her knees and ankles, elbows and legs; This is a spontaneous report from a contactable consumer. A female patient of 62-year-old age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 12May2021 dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. Her main concern is getting the 2nd dose of the vaccine. She had her 1st dose of the vaccine on 12May2021, she had a weird reaction that is not indicated in the side effects form, and she had re-ported it already. On 19May2021 patient experienced a shock sensation that would travel from her shoulder to her belly, to her knees and ankles, elbows and legs 7 days after the injection and it lasted for about a week. She's supposed to receive the 2nd dose in June, but her brother passed away and she needs to get to (place withheld) to handle everything, she just got back home in (place withheld) and now she needs guidance in getting the 2nd dose of the vaccine. The outcome of the event was recovered on an unspecified date.  Information on the lot/batch number has been requested.
Patient said shortly after receiving shot she felt tightness across shoulders, back of neck. Stated she did not have any difficulty breathing. Called her about 3:55 she was feeling better and was eating a sandwich.
Patient fainted in the store after vaccination but regained conscious shortly. She decided not to leave with the ambulance.
THIS LOCATION WAS INSTRUCTED TO PICK UP PFIZER VACCINE FROM HUB  STORE FOR USE 3/24/21 AND 3/25/21. THERE WAS NO EXPIRATION DATE OR  SIMILAR INFO ON THE PACKAGING IN WHICH WE RECEIVED THE VACCINE  AND DILUENT. SINCE WE WERE TOLD TO USE THE VACCINE ON THESE DAYS  ONLY (WE NORMALLY USE MODERNA), THE ASSUMPTION WAS THAT THE  VACCINE WOULD BE WITHIN ITS BUD/TIME. OUR STORE MANAGER WAS  INFORMED AT END-OF-DAY ON 3/25/21 THAT VACCINE HAD EXPIRED AT 11:00 AM THAT DAY. CONSULTATION WITH PFIZER INDICATED THAT THE DOSE DID  NOT HAVE TO BE REPEATED FOR PATIENT.
Local erythema, swelling of whole arm and slight pain and itching fever 100.5 degrees; all these were noted 18 hours after vaccination.
On 10/31/2000, the patient developed 20+ lesions on her chest, back and arms showing dermatomal distribution and was subsequently diagnosed with herpes zoster. The health professional noted that no other symptoms were noted. Additional information has been requested.
Narrative:  Pt died 3/22/2022 while hospitalized at hospital.
Body aches; headaches; extremely tired; waking up the following morning drenched in sweat; This is a spontaneous report from a contactable consumer (friend). A 23-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient was not pregnant. On an unspecified date the patient experienced body aches and headaches. Also reported feeling extremely tired and waking up the following morning "drenched in sweat". None of the reported effects were described as severe and the effects were a part of casual conversation. Outcome of the events was recovered on an unspecified date.   Information on lot number/batch number was requested.
This spontaneous report was received rom a pharmacy technician regarding a patient unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 01-AUG-2016, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (dose and route of administration were not reported, lot # L044529, expiration date 09-FEB-2017). There was no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 32 degrees Fahrenheit for 2 hours. There was no data logger involved. Additional information has been requested.
Left arm with widespread edema from shoulder to wrist erythema spreading despite antihistamines and antibiotics.  Warm to touch, skin beginning to tighten.  Left arm 2 x size of right arm.
Dizziness, nausea, vomiting, excruciating headache, and shortness of breath at times.
Information has been received from a registered nurse concerning a 71 year old female with lipidaemia, rhinitis allergic, hypertension, coronary artery disease, hypothyroidism and homocysteine level increased and a history of menopause who on 15-APR-2008 was vaccinated SQ with a second or third 0.5 mL dose of pneumococcal 23v polysaccharide vaccine (Lot# 659199/1541U). Concomitant therapy included AVALID, PREMARIN, TRIGLIDE, TOPROL XL TABLETS, LIPITOR, LEVO, ZYRTEC, folic acid and NASACORT. On 19-APR-2008, the patient developed cellulitis. The patient had a high temperature, a swollen lymph node under the arm and malaise. On 21-APR-2008, she was treated with an unspecified antibiotic. At the time of this report, the patient was recovering. No product quality complaint was involved. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for biologics Evaluation and Research and was released. This is one of three reports from the same source. Additional information has been requested.
The pt experienced body aches, severe soreness in the right armpit, slight elevated temp, tiredness, took Tylenol and was better the next day.
Onset urticaria 3/12/21. ED visit 3/14/21. Syncopal episode in context of rash 3/17/21 leading to hospitalization 3/17-8/21. Benadryl, loratadine, famotidine, cephalexin for UTI. 2nd Moderna shot 3/27/21. 4/2 Office visit dizzy, weak, headaches, nausea, loss of appetite since 2nd vaccine Na 127. 4/16 Office visit for Headache, neck pain. 4/25 ED visit for dizziness. MRI head NL, labs mild hyponatremia. Given meclizine. 4/27-8 Hospitalization for dizziness, orthostasis, URI symptoms. OC43 Coronavirus, orthostasis. Alb 2.7 Globulin 5. New cervical and axillary Lymph adenopathy. 5/8/21 admitted to hospital w/ new diagnosis of lymphoma (pathologic diagnosis Nodal peripheral T cell lymphoma w/ follicular helper phenotype. Large axillary lymphadenopathy, thrombocytopenia, elevated total protein, acute kidney injury, anemia. 5/15/21 patient passed away from acute hypoxic respiratory failure in the setting of new lymphoma diagnosis.
Chills, fever lasting from 4:30 am 10/6 through 12:30 pm 10/7, headache, painful muscles over entire body, painful at injection site and unable to raise arm without pain, unable to work due to fever, now an itchy rash is developing around injection site. Same symptoms occurred with first injection except for itchy rash.
patient complained she couldnt get out of bed the morning after her immunizations. she said she had to sit on the floor and crawl to her phone and it took her a couple hours to get out of bed and she felt terrible the rest of the day and wanted to let someone know that she does not think these vaccines should be recommended at the same time.
One day after receiving the 2nd dose of the Pfizer Covid-19 vaccine at the vaccination site, I began developing severe chest pain. I first went to the Urgent Care where I was evaluated and received bloodwork, a chest X Ray, and an EKG . The EKG and chest X ray appeared normal, however, it was found that I had an elevated d-dimer so I was sent to the Hospital emergency room for a possible blood clot. At the emergency room, I was subjected to an evaluation and a CT scan. Ultimately the ER doctor (Dr. MD)  was unable to find the source of the chest pain and did not find a blood clot, so I was sent home. However, I have continued to have chest pain off and on ever since the second dose of the vaccine and it has not resolved 6 months later. I never had chest pain in my life prior to receiving this vaccination. I am extremely fit and healthy, low BMI and only 23 years old at the time of vaccination. The pain now exists towards the right side of the center of my chest and is persistent.   I am able to provide the Physician records of the ER visit and the CT scan if required. I am hoping to receive exemption from any future booster requirements due to my severe reaction to the 2nd dose.
fever to 101.9-swollen leg-not eating-not sleeping well-very fussy-knot at site;
PATIENT FAINTED WITHIN 5 MINUTES OF VACCINE, BUT REGAINED CONSCIOUSNESS QUICKLY. PATIENT APPEARED PALE. PATIENT REMAINED SEATED FOR 30 MINUTES AND PARAMEDICS ARRIVED TO CONDUCT EVALUATION OF PATIENT.